Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial

Pradeesh Sivapalan, Charlotte Suppli Ulrik, Rasmus Dahlin Bojesen, Therese Sophie Lapperre, Josefin Viktoria Eklöf, Kjell Erik Julius Håkansson, Andrea Browatzki, Casper Tidemansen, Jon Torgny Wilcke, Julie Janner, Vibeke Gottlieb, Howraman Meteran, Celeste Porsbjerg, Birgitte Lindegaard Madsen, Mia Moberg, Lars Pedersen, Thomas Lars Benfield, Jens Dilling Lundgren, Filip Krag Knop, Tor Biering-SørensenMuzhda Ghanizada, Tine Peick Sonne, Uffe Christian Steinholtz Bødtger, Sidse Graff Jensen, Daniel Bech Rasmussen, Eva Brøndum, Oliver Djurhuus Tupper, Susanne Wiemann Sørensen, Gitte Alstrup, Christian Borbjerg Laursen, Ulla Weinrich Møller, Asger Sverrild, Jens-Ulrik Stæhr Jensen

Research output: Contribution to journalLetterResearchpeer-review

6 Citations (Scopus)
14 Downloads (Pure)
Original languageEnglish
Article number513
JournalTrials
Volume21
Issue number1
Number of pages4
ISSN1745-6215
DOIs
Publication statusPublished - 10 Jun 2020

Keywords

  • Antiviral Agents/administration & dosage
  • Azithromycin/administration & dosage
  • Betacoronavirus/drug effects
  • Coronavirus Infections/diagnosis
  • Critical Care
  • Denmark
  • Double-Blind Method
  • Drug Administration Schedule
  • Hospital Mortality
  • Host-Pathogen Interactions
  • Humans
  • Hydroxychloroquine/administration & dosage
  • Inpatients
  • Length of Stay
  • Multicenter Studies as Topic
  • Noninvasive Ventilation
  • Pandemics
  • Patient Admission
  • Pneumonia, Viral/diagnosis
  • Randomized Controlled Trials as Topic
  • Severity of Illness Index
  • Time Factors
  • Treatment Outcome
  • COVID-19
  • protocol
  • hydroxychloroquine
  • azithromycin
  • respiratory infections
  • Randomised controlled trial

Fingerprint

Dive into the research topics of 'Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial'. Together they form a unique fingerprint.

Cite this